Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Aesthetic Ophthalmology Devices
... at a CAGR of 7.9% over the analysis period 2024-2030. Diagnostic Devices, one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$837.6 Million by the end of ... Read More
-
Intrauterine Insemination
... CAGR of 8.1% over the analysis period 2024-2030. The U.S. Market is Estimated at US$464.8 Million While China is Forecast to Grow at 11.7% CAGR The Intrauterine Insemination market in the U.S. is estimated at ... Read More
-
Lumbosacral Orthosis (LSO)
... at a CAGR of 3.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$128.7 Million While China is Forecast to Grow at 5.6% CAGR The Lumbosacral Orthosis (LSO) market in the U.S. ... Read More
-
Knee Braces
... CAGR of 5.2% over the analysis period 2024-2030. Functional Knee Braces, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$875.4 Million by the end of the ... Read More
-
Eye Allergy Therapeutics
... at a CAGR of 5.5% over the analysis period 2024-2030. Antihistamines, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.2 Billion by the end of the ... Read More
-
Gastrointestinal Videoscopes
... CAGR of 6.4% over the analysis period 2024-2030. Hospitals Application, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$5.3 Billion by the end of the analysis ... Read More
-
Hematology Testing Products
... at a CAGR of 4.4% over the analysis period 2024-2030. Hematology Testing Instruments & Software, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$9.8 Billion by ... Read More
-
Tumor / Cancer Markers
... 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 10.4% CAGR The Tumor / Cancer Markers market ... Read More
-
Corticosteroids Therapy
... CAGR of 4.6% over the analysis period 2024-2030. Glucocorticoids, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$4.1 Billion by the end of the analysis period. ... Read More
-
Anti-Allergy Drugs
... CAGR of 7.1% over the analysis period 2024-2030. Pharmacies End-Use, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$35.4 Billion by the end of the analysis ... Read More
-
Spinal Muscular Atrophy
... at a CAGR of 12.3% over the analysis period 2024-2030. Type 1 Spinal Muscular Atrophy, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$2.4 Billion by ... Read More
-
Angiography Devices
... CAGR of 3.9% over the analysis period 2024-2030. Angiography Systems, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$5.8 Billion by the end of the analysis ... Read More
-
Chronic Myelogenous Leukemia Treatment
... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Disease Specific Treatment, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.4 Billion by ... Read More
-
Dental Bioimplants
... CAGR of 7.5% over the analysis period 2024-2030. Plate Form Dental Implant, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$15.0 Billion by the end of ... Read More
-
Microwave Ablation
... CAGR of 13.2% over the analysis period 2024-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$215.5 Million by the end of the ... Read More
-
Retinal Laser Equipment
... at a CAGR of 7.1% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$693.0 Million by the end of ... Read More
-
Anxiolytics
... 4.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$259.8 Million While China is Forecast to Grow at 7.1% CAGR The Anxiolytics market in the U.S. is estimated at US$259.8 Million in ... Read More
-
Home Pregnancy Tests (HPT)
... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Digital Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$597.6 Million by the ... Read More
-
Bulk Paclitaxel
... CAGR of 8.5% over the analysis period 2024-2030. Semi-Synthetic Paclitaxel API, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$139.1 Million by the end of the ... Read More
-
Airway Clearance Systems
... at a CAGR of 4.7% over the analysis period 2024-2030. Positive Expiratory Pressure (PEP) Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$396.2 Million by ... Read More
-
Asthma Therapeutics
... CAGR of 2.3% over the analysis period 2024-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$10.7 Billion by the end of the analysis ... Read More
-
Benign Prostatic Hyperplasia Devices
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. TURP Procedure, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$389.8 Million by the ... Read More
-
Breast Cancer Screening
... at a CAGR of 5.1% over the analysis period 2024-2030. Imaging Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.8 Billion by the end of ... Read More
-
Breast Implants
... CAGR of 6.0% over the analysis period 2024-2030. Silicone Implants, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$4.2 Billion by the end of the analysis ... Read More
-
Cancer Gene Therapy
... at a CAGR of 20.9% over the analysis period 2024-2030. Oncolytic Virotherapy, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$4.3 Billion by the end of ... Read More
Research Assistance
